A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea-Reference-Cited by-同舟云学术

A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea

Published:2014-09 Issue:5 Volume:29 Page:279-287
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Lee Nam Young,Kim Se Hyun,Cho Seong Jin,Chung Young-Cho,Jung In Kwa,Kim Chang Yoon,Kim Duk Ho,Lee Dong Geun,Lee Yo Han,Lim Weon Jeong,Na Young Suk,Shin Sang Eun,Woo Jong-Min,Yoon Jin Sang,Yoon Bo-Hyun,Ahn Yong Min,Kim Yong Sik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference26 articles.

1. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention

2. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

3. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review

4. Long-acting risperidone improves negative symptoms in stable psychotic patients

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia;Brain Sciences;2023-11-10

2. Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review;Neuropsychiatric Disease and Treatment;2023-09

3. Breakthrough Psychosis and Long-Acting Injectable Antipsychotics;Korean Journal of Schizophrenia Research;2023-04-30

4. Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting;Clinical Psychopharmacology and Neuroscience;2022-08-31

5. Discontinuation rates during long‐term, second‐generation antipsychotic long‐acting injection treatment: A systematic review;Psychiatry and Clinical Neurosciences;2019-03-06